| Document and Entity Information | 9 Months Ended | |
| Sep. 30, 2013 | Nov. 18, 2013 | |
| Document and Entity Information [Abstract] | ' | ' |
| Document Type | '10-Q | ' |
| Amendment Flag | 'false | ' |
| Document Period End Date | 30-Sep-13 | ' |
| Document Fiscal Year Focus | '2013 | ' |
| Document Fiscal Period Focus | 'Q3 | ' |
| Entity Registrant Name | 'AXIM INTERNATIONAL INC. | ' |
| Entity Central Index Key | '0001514946 | ' |
| Current Fiscal Year End Date | '--12-31 | ' |
| Entity Filer Category | 'Smaller Reporting Company | ' |
| Entity Common Stock, Shares Outstanding | ' | 33,000,000 |
| CONDENSED BALANCE SHEETS (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
| Current Assets | ' | ' |
| Cash | $1,235 | $19,128 |
| License fee receivable | 11,000 | 20,000 |
| Less: Allowance for doubtful accounts | -7,500 | ' |
| Total Current Assets | 4,735 | 39,128 |
| Other Assets | ' | ' |
| Intangible asset - License | 100,000 | 100,000 |
| Less: accumulated amortization | -13,804 | -6,304 |
| Total Other Assets | 86,196 | 93,696 |
| TOTAL ASSETS | 90,931 | 132,824 |
| Current Liabilities | ' | ' |
| Accounts payable and accrued expenses | 46,726 | 32,570 |
| Deferred revenue | ' | 21,667 |
| Royalty fees payable | 2,750 | 2,300 |
| Due to shareholder | 42,407 | 30,985 |
| Convertible shareholder loan | 50,000 | 50,000 |
| Total liabilities | 141,883 | 137,522 |
| SHAREHOLDERS' DEFICIT | ' | ' |
| Preferred stock, $0.0001 par value, 5,000,000 shares authorized; 1,000,000 issued and outstanding | 100 | 100 |
| Common stock, $0.0001 par value, 195,000,000 shares authorized; 33,000,000 issued and outstanding | 3,300 | 3,300 |
| Capital in excess of par value | 11,700 | 11,700 |
| Accumulated Deficit | -66,052 | -19,798 |
| Total shareholders' deficit | -50,952 | -4,698 |
| TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT | $90,931 | $132,824 |
| CONDENSED BALANCE SHEETS (Parenthetical) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
| CONDENSED BALANCE SHEETS [Abstract] | ' | ' |
| Preferred stock, par value | $0.00 | $0.00 |
| Preferred stock authorized shares | 5,000,000 | 5,000,000 |
| Preferred stock shares issued | 1,000,000 | 1,000,000 |
| Preferred stock shares outstanding | 1,000,000 | 1,000,000 |
| Common stock, par value | $0.00 | $0.00 |
| Common stock authorized shares | 195,000,000 | 195,000,000 |
| Common stock shares issued | 33,000,000 | 33,000,000 |
| Common stock shares outstanding | 33,000,000 | 33,000,000 |
| CONDENSED STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | 9 Months Ended | 34 Months Ended | ||
| Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | |
| CONDENSED STATEMENTS OF OPERATIONS [Abstract] | ' | ' | ' | ' | ' |
| Revenues | $10,833 | $10,833 | $21,667 | $32,500 | $74,999 |
| General and administrative expenses | 10,643 | 12,600 | 67,921 | 43,351 | 141,051 |
| Net income (loss) | $190 | ($1,767) | ($46,254) | ($10,851) | ($66,052) |
| Loss per common share - basic and diluted | ' | ' | ' | ' | ' |
| Weighted average number of common shares outstanding | 33,000,000 | 33,000,000 | 33,000,000 | 33,000,000 | ' |
| CONDENSED STATEMENTS OF CASH FLOWS (USD $) | 9 Months Ended | 34 Months Ended | |
| Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ' | ' | ' |
| Net loss | ($46,254) | ($10,851) | ($66,052) |
| Charges not requiring the outlay of cash: | ' | ' | ' |
| Amortization of intangible asset | 7,500 | 3,750 | 13,804 |
| Increase in allowance for doubtful accounts | 7,500 | ' | 7,500 |
| Share issuance for organization expense | ' | ' | 2,100 |
| Changes in assets and liabilities: | ' | ' | ' |
| Decrease (increase) in license fee receivable | 9,000 | 30,000 | -11,000 |
| Increase in accounts payable and accrued expenses | 14,156 | 18,110 | 46,726 |
| Decrease in deferred revenue | -21,667 | -32,500 | ' |
| Increase in royalty fees payable | 450 | 1,350 | 2,750 |
| Net cash provided (consumed) by operating activities | -29,315 | 9,859 | -4,172 |
| CASH FLOWS FROM INVESTING ACTIVITES | ' | ' | ' |
| Acquisition of license | ' | -50,000 | -100,000 |
| Net cash consumed by investing activities | ' | -50,000 | -100,000 |
| CASH FLOWS FROM FINANCING ACTIVITIES | ' | ' | ' |
| Proceeds from the issuance of common shares | ' | ' | 13,000 |
| Proceeds from shareholder loans | 11,422 | 24,510 | 42,407 |
| Proceeds from convertible shareholder loan | ' | ' | 50,000 |
| Net cash provided by financing activities | 11,422 | 24,510 | 105,407 |
| Net changes in cash | -17,893 | -15,631 | 1,235 |
| Cash, at beginning of period | 19,128 | 23,138 | ' |
| Cash, at end of period | $1,235 | $7,507 | $1,235 |
| BASIS OF PRESENTATION | 9 Months Ended |
| Sep. 30, 2013 | |
| BASIS OF PRESENTATION [Abstract] | ' |
| BASIS OF PRESENTATION | ' |
| NOTE 1: BASIS OF PRESENTATION: | |
| The unaudited interim financial statements of Axim International, Inc. as of September 30, 2013, and for the three and nine month periods ended September 30, 2013 and 2012, have been prepared in accordance with United States generally accepted accounting principles. In the opinion of management, such information contains all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the results of such periods. The results of operations of the nine month period ended September 30, 2013 are not necessarily indicative of the results to be expected for the full year ending December 31, 2013. | |
| Certain information and disclosures normally included in the notes to financial statements have been condensed or abbreviated as permitted by the rules and regulations of the Securities and Exchange Commission, although the Company believes the disclosure is adequate to make the information not misleading. The accompanying unaudited financial statements should be read in conjunction with the financial information of the fiscal year ended December 31, 2012. | |
| RELATED PARTY TRANSACTIONS | 9 Months Ended |
| Sep. 30, 2013 | |
| RELATED PARTY TRANSACTIONS [Abstract] | ' |
| RELATED PARTY TRANSACTIONS | ' |
| NOTE 2: RELATED PARTY TRANSACTIONS | |
| From inception (November 18, 2010) to September 30, 2013, the Company president advanced a total of $ 42,407 to fund working capital needs. That advance bears no interest and is due on demand. | |
| On September 26, 2013, the Company president advanced $ 5,000 for a payment to extend the contract with Omega Research Corporation until December 31, 2013. | |
| Effective November 26, 2012, the Company entered into a separate Convertible Loan Agreement with its President, under which it borrowed $50,000. This loan is due December 31, 2014 and does not bear interest. The loan is convertible into common stock at $.10 per share at the option of the lender any time after February 28, 2013. As of September 30, 2013, the loan has not been converted. The Company used the proceeds of this loan to fund the purchase of license rights under the November 26, 2012 agreement with Omega Research Corporation. |
| GOING CONCERN | 9 Months Ended |
| Sep. 30, 2013 | |
| GOING CONCERN [Abstract] | ' |
| GOING CONCERN | ' |
| NOTE 3. GOING CONCERN | |
| The Company's financial statements have been presented assuming that the Company will continue as a going concern. As shown in the financial statements, the Company has negative working capital, has an accumulated deficit of $ 66,052, and presently does not have the resources to accomplish its objectives during the next twelve months. These conditions raise substantial doubt about the ability of the Company to continue as a going concern. The financial statements do not include any adjustments related to the recoverability of assets and classification of liabilities that might be necessary should the Company be unable to continue in operation. |
| RELATED PARTY TRANSACTIONS (Details) (USD $) | 1 Months Ended | 9 Months Ended | 34 Months Ended | 1 Months Ended | |
| Sep. 30, 2013 | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Nov. 26, 2012 | |
| President [Member] | |||||
| Convertible Loan Agreement One [Member] | |||||
| Related Party Transaction [Line Items] | ' | ' | ' | ' | ' |
| Advances to fund working capital needs | $5,000 | $11,422 | $24,510 | $42,407 | ' |
| Debt instrument, face amount | ' | ' | ' | ' | $50,000 |
| Debt instrument, conversion price | ' | ' | ' | ' | $0.10 |
| Debt instrument, due date | ' | ' | ' | ' | 31-Dec-14 |
| Debt instrument, issuance date | ' | ' | ' | ' | 28-Feb-13 |
| GOING CONCERN (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
| GOING CONCERN [Abstract] | ' | ' |
| Accumulated Deficit | $66,052 | $19,798 |
